Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study
Launched by HOPITAL FOCH · Sep 15, 2016
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • more than 18 years, -no legal protection, -
- • life expectancy is considered over 3-months
- • not receiving of béta-blocking,
- • Having a rhythm sinusal without extrasystole
- • benefiting from a coverage by a social security system
- Exclusion Criteria:
- • Pace-Maker
- • Diabetes mellitus
About Hopital Foch
Hospital Foch is a leading healthcare institution located in Suresnes, France, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, Hospital Foch actively engages in the development of new therapeutic approaches across various medical disciplines, facilitating cutting-edge studies that aim to enhance treatment outcomes and improve patient quality of life. With a multidisciplinary team of experienced researchers and healthcare professionals, the hospital fosters a collaborative environment that prioritizes ethical standards and scientific rigor, ensuring the highest quality in clinical trial execution and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suresnes, , France
Patients applied
Trial Officials
Marc Fischler
Principal Investigator
Hopital Foch
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials